WEKO3
アイテム
Risk factors for brain injury after carbon ion radiotherapy for skull base tumors.
https://repo.qst.go.jp/records/46787
https://repo.qst.go.jp/records/467872f23fa98-bc0b-4f89-8325-486404279528
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2014-07-22 | |||||
タイトル | ||||||
タイトル | Risk factors for brain injury after carbon ion radiotherapy for skull base tumors. | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Koto, Masashi
× Koto, Masashi× Hasegawa, Azusa× Takagi, Ryo× Fujikawa, Akira× Morikawa, Takamichi× Kishimoto, Riwa× Jingu, Keiichi× Tsujii, Hirohiko× Kamada, Tadashi× 小藤 昌志× 長谷川 安都佐× 高木 亮× 藤川 陽× 森川 貴迪× 岸本 理和× 辻井 博彦× 鎌田 正 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | BACKGROUND AND PURPOSE: This study aimed to determine the risk factors for radiation-induced brain injury (RIBI) after carbon ion radiotherapy (CIRT) for treating skull base tumors. \nMATERIALS AND METHODS: Between April 1997 and January 2009, CIRT at a total dose of 48.0-60.8Gy equivalent (GyE) was administered in 16 fractions to 47 patients with skull base tumors. Of these patients, 39 who were followed up with magnetic resonance imaging (MRI) for more than 24months were analyzed. RIBI was assessed according to the MRI findings based on the Late Effects of Normal Tissue-Subjective, Objective, Management, Analytic criteria; clinical symptoms were assessed according to the Radiation Therapy Oncology Group/European Organisation for Research and Treatment of Cancer tables. The correlations of clinical and dosimetric parameters with incidence of ⩾grade 2 RIBI were retrospectively analyzed. \nRESULTS: The median follow-up period was 67months. The 5-year actuarial likelihoods of ⩾grade 2 RIBI and ⩾grade 2 clinical symptoms were 24.5% and 7.0%, respectively. Multivariate analysis demonstrated that the brain volume receiving more than 50GyE (V50) was a significant risk factor for the development of ⩾grade 2 RIBI (p=0.004). \nCONCLUSION: V50 was a significant risk factor for ⩾grade 2 RIBI after CIRT using a 16-fraction regimen. |
|||||
書誌情報 |
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 巻 111, 号 1, p. 25-29, 発行日 2013-12 |
|||||
出版者 | ||||||
出版者 | Elsevier Scientific Publishers | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0167-8140 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 24332023 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1016/j.radonc.2013.11.005 | |||||
関連サイト | ||||||
識別子タイプ | URI | |||||
関連識別子 | www.thegreenjournal.com | |||||
関連名称 | www.thegreenjournal.com |